CRISPR-Cas9 technology Archives

News & Features

CRISPR-Based “Genome Shredding” Technique Shows Promise in Treating Glioblastoma

Uduak Thomas -

November 29, 2023

News & Features

U.K. Approves Vertex/CRISPR Tx’s Casgevy for Sickle Cell and Beta Thalassemia

Malorye Branca -

November 16, 2023

News & Features

CRISPR-Based Epigenome Editing Platform Identifies Genes That Improve T-Cell Therapies for Cancer Treatment

Chris Anderson -

November 15, 2023

News & Features

Protein Identified That Is a Key Driver of Cancer Cell Necrosis

Christina Jackson -

August 2, 2023

News & Features

One and Done? How CRISPR Is Changing the Clinical Outlook for Multiple Diseases

Kathy Vuksanaj -

June 5, 2023

News & Features

CRISPR-Cas Used against Antimicrobial Resistance

Malorye Branca -

May 25, 2023

News & Features

Organoids Provide Insights into Rare Liver Cancer

Chris Anderson -

May 3, 2023

An illustration of a CRISPR-Cas9 gene editing protein cutting a DNA helix

News & Features

Key Improvement in Targeting Could Bring in Next Generation Cell and Gene Therapies

Helen Albert -

May 1, 2023

News & Features

New Nanoparticles Carrying mRNA Can Perform In-Lung Gene Editing

Chris Anderson -

March 30, 2023

News & Features

Study Significantly Improves CAR T Cell Therapy for Solid Tumors

Alisa Kirkin -

March 16, 2023

12 3...9 Page 1 of 9

Separate Studies Show Why Some Prostate Cancers Become Resistant to Hormone…

Generative AI Experts Absci Partner with AstraZeneca to Develop Cancer Treatment

In Big Obesity Move, Roche Acquires Carmot Therapeutics for $2.7B Up…

AbbVie Buys ImmunoGen for $10.1B to Speed Entry into Ovarian Cancer…

Biological Robots Show Healing Potential

CRISPR-Cas9 technology

CRISPR-Based “Genome Shredding” Technique Shows Promise in Treating Glioblastoma

U.K. Approves Vertex/CRISPR Tx’s Casgevy for Sickle Cell and Beta Thalassemia

CRISPR-Based Epigenome Editing Platform Identifies Genes That Improve T-Cell Therapies for Cancer Treatment

Protein Identified That Is a Key Driver of Cancer Cell Necrosis

One and Done? How CRISPR Is Changing the Clinical Outlook for Multiple Diseases

CRISPR-Cas Used against Antimicrobial Resistance

Organoids Provide Insights into Rare Liver Cancer

Key Improvement in Targeting Could Bring in Next Generation Cell and Gene Therapies

New Nanoparticles Carrying mRNA Can Perform In-Lung Gene Editing

Study Significantly Improves CAR T Cell Therapy for Solid Tumors

Related Content

Mayo Clinic, Columbia University Receive $10.6M NCI Grant for Glioblastoma Research

U.K. Approves Vertex/CRISPR Tx’s Casgevy for Sickle Cell and Beta Thalassemia

CRISPR-Based Epigenome Editing Platform Identifies Genes That Improve T-Cell Therapies for Cancer Treatment

Effect of CSF on Glioblastoma Suggests Anti-Anxiety Drug Could Improve Treatment Response